Most Read Articles
Roshini Claire Anthony, 4 days ago

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Stephen Padilla, 5 days ago
Implementation of the collaborative care in a rheumatoid arthritis (RA) clinic has led to improvements in nonbiologic disease-modifying antirheumatic drugs (nb-DMARDs) optimization, adherence to safety recommendations on nb-DMARD monitoring and detection of adverse drug events in RA patients, according to a Singapore study.
Prof. John Paul Leach, Prof. Patrick Kwan, 3 days ago
A new synaptic vesicle 2A (SV2A) ligand, brivaracetam, is one of the most recent antiepileptic drugs (AEDs) approved in Hong Kong. At a recent UCB-sponsored symposium organized by the Hong Kong Epilepsy Society, Professor John Paul Leach of the Queen Elizabeth University Hospital in Glasgow, UK, and Professor Patrick Kwan of Monash University in Melbourne, Australia, discussed the role of brivaracetam in the treatment of epilepsy and presented real-world data on this new SV2A ligand.
4 days ago
Short sleep duration is associated with an increased risk of myocardial infarction (MI), according to prospective observational and Mendelian randomization (MR) analyses.

New AI-based platform streamlines drug prescription, minimizes errors

Jackey Suen
24 Jan 2019
Zain Rana, CEO of Pharmeum

An innovative healthcare platform has been developed and trialed in the UK to enhance the efficiency of drug prescriptions and possibly reduce medical errors.

The Pharmeum platform contains patients’ medical data and allows patients to instantly grant access to their data to any healthcare provider.

Pharmeum can be accessed through a dedicated mobile phone application. An artificial intelligence (AI) software is incorporated into the system to dynamically analyze medical data and minimize medical errors.

“The platform also allows users to send and receive digital prescriptions. Patients are given complete control over their prescriptions because Pharmeum lists all nearby pharmacies and prices of the prescribed medicines. This price transparency will improve the affordability of medicines for patients,” explained Zain Rana, CEO of Pharmeum. “The system is empowered by the Blockchain technology to ensure secure transfer as well as use of prescriptions and medical data.”

“The app will be free for patients. Revenue will be generated by taking a 0.5–1.0 percent commission from pharmacies on each sale through the platform,” he explained.

“We hope that Pharmeum can help patients monetize their medical data securely, help clinicians minimize errors, and help pharmacies improve productivity and revenue,” concluded Rana.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Hong Kong digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Stephen Padilla, 5 days ago
Implementation of the collaborative care in a rheumatoid arthritis (RA) clinic has led to improvements in nonbiologic disease-modifying antirheumatic drugs (nb-DMARDs) optimization, adherence to safety recommendations on nb-DMARD monitoring and detection of adverse drug events in RA patients, according to a Singapore study.
Prof. John Paul Leach, Prof. Patrick Kwan, 3 days ago
A new synaptic vesicle 2A (SV2A) ligand, brivaracetam, is one of the most recent antiepileptic drugs (AEDs) approved in Hong Kong. At a recent UCB-sponsored symposium organized by the Hong Kong Epilepsy Society, Professor John Paul Leach of the Queen Elizabeth University Hospital in Glasgow, UK, and Professor Patrick Kwan of Monash University in Melbourne, Australia, discussed the role of brivaracetam in the treatment of epilepsy and presented real-world data on this new SV2A ligand.
4 days ago
Short sleep duration is associated with an increased risk of myocardial infarction (MI), according to prospective observational and Mendelian randomization (MR) analyses.